<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="unc80-def" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">unc80-def</book-part-id>
      <title-group>
        <title>UNC80 Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Boerkoel</surname>
            <given-names>Cornelius</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Clinical Associate Professor, Provincial Medical Genetics Program<break/>Department of Medical Genetics <break/>University of British Columbia<break/>Children's and Women's Health Centre of BC<break/>Vancouver, British Columbia, Canada</aff>
          <email>cboerkoel@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>du Souich</surname>
            <given-names>Christ&#x000e8;le</given-names>
          </name>
          <degrees>MSc</degrees>
          <aff>Clinical Assistant Professor, Provincial Medical Genetics Program<break/>Department of Medical Genetics<break/>University of British Columbia<break/>Children's and Women's Health Centre of BC<break/>Vancouver, British Columbia, Canada</aff>
          <email>cdusouich@cw.bc.ca</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>21</day>
          <month>9</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="tyrosinemia" document-type="chapter">Tyrosinemia Type I</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="udd" document-type="chapter">Udd Distal Myopathy</related-object>
      <abstract id="unc80-def.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>UNC80 deficiency is characterized by hypotonia, strabismus, oral motor dysfunction, postnatal growth deficiency, and global developmental delay. The majority of individuals do not learn to walk. All individuals lack expressive language; however, many have expressive body language, and a few have used signs to communicate. Seizures may develop during infancy or childhood. Additional features can include nystagmus, extremity hypertonia, a high-pitched cry, repetitive and self-stimulatory behaviors, constipation, club feet, joint contractures, and scoliosis. For most individuals the UNC80 deficiency syndrome is not progressive. Individuals have slow acquisition of skills and do not have a loss of skills suggestive of neurodegeneration.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of UNC80 deficiency is established in a proband with global developmental delay and hypotonia by identification of biallelic pathogenic variants in <italic toggle="yes">UNC80</italic> on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> G-tube feeding as needed for oral feeding difficulties; antiepileptic medications for seizure management; physical and occupational therapy for motor delay and sensory processing difficulties; ophthalmologic management for strabismus; braces and corrective surgeries as needed for orthopedic abnormalities; empiric management of constipation; sign language instruction or use of an alternate communication device for absent speech.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual evaluations for growth assessment, back exam for scoliosis, seizure management, evaluation of contractures, and ophthalmology examination.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>UNC80 deficiency is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal diagnosis for pregnancies at increased risk are possible if both pathogenic variants in a family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="unc80-def.Diagnosis">
        <title>Diagnosis</title>
        <p>No formal diagnostic criteria have been published.</p>
        <sec id="unc80-def.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>UNC80 deficiency <bold>should be suspected</bold> in individuals with the following clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Global developmental delay</p>
            </list-item>
            <list-item>
              <p>Moderate-to-severe intellectual disability</p>
            </list-item>
            <list-item>
              <p>Absent speech (&#x0003c;5 words)</p>
            </list-item>
            <list-item>
              <p>Hypotonia</p>
            </list-item>
            <list-item>
              <p>Joint contractures</p>
            </list-item>
            <list-item>
              <p>Postnatal growth restriction</p>
            </list-item>
          </list>
        </sec>
        <sec id="unc80-def.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of UNC80 deficiency <bold>is established</bold> in a proband with global developmental delay and hypotonia by identification of biallelic pathogenic variants in <italic toggle="yes">UNC80</italic> on molecular genetic testing (see <xref ref-type="table" rid="unc80-def.T.molecular_genetic_testing_us">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include a combination of <bold>gene-targeted testing</bold> (single-gene testing or a multi-gene panel) and <bold>genomic testing</bold> (comprehensive genome sequencing) depending on the phenotype.</p>
          <p>Gene-targeted testing requires that the clinician determine which gene(s) are likely involved, whereas genomic testing does not. Because the phenotypes of many disorders with hypotonia, global developmental delay, and intellectual disability overlap, most children with UNC80 deficiency are diagnosed by the following genomic testing options:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Comprehensive genome sequencing</bold> (when clinically available) that includes exome sequencing and genome sequencing is one option. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">UNC80</italic> and other genes of interest (see <xref ref-type="sec" rid="unc80-def.Differential_Diagnosis">Differential Diagnosis</xref>) is another option. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of a condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying phenotype. Of note, given the rarity of UNC80 deficiency, many panels for intellectual disability may not include this gene. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing-based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <p>Note: Single-gene testing (sequence analysis of <italic toggle="yes">UNC80</italic>) is rarely useful and typically NOT recommended.</p>
          <table-wrap id="unc80-def.T.molecular_genetic_testing_us" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in UNC80 Deficiency</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_unc80-def.T.molecular_genetic_testing_us_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_unc80-def.T.molecular_genetic_testing_us_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_unc80-def.T.molecular_genetic_testing_us_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_unc80-def.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">UNC80</italic>
                  </td>
                  <td headers="hd_h_unc80-def.T.molecular_genetic_testing_us_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_unc80-def.T.molecular_genetic_testing_us_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">19/19&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.molecular_genetic_testing_us_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_unc80-def.T.molecular_genetic_testing_us_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="unc80-def.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="unc80-def" object-id="unc80-def.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="unc80-def.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="unc80-def.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="unc80-def.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="unc80-def.TF.1.4">
                <label>4. </label>
                <p>
                  <xref ref-type="bibr" rid="unc80-def.REF.valkanas.2016.3106">Valkanas et al [2016]</xref>
                </p>
              </fn>
              <fn id="unc80-def.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="unc80-def.TF.1.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="unc80-def.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="unc80-def.Clinical_Description">
          <title>Clinical Description</title>
          <p>UNC80 deficiency is a multisystem disorder. <xref ref-type="table" rid="unc80-def.T.frequency_of_clinical_featur">Table 2</xref> indicates the frequency of clinical findings in this condition based on published reports. Clinical features vary and current evidence suggests dependency on the nature of the genetic variations.</p>
          <p><bold>Neurodevelopmental features.</bold> Individuals have congenital central hypotonia and strabismus. Some also manifest extremity hypertonia and a high-pitched cry. Seizures may develop during infancy or childhood. Focal seizures, generalized tonic-clonic seizures, myotonic seizures, aclonic seizures and atypical absence seizures have been described. All respond well to anti-convulsive medications.</p>
          <p>All individuals have global developmental delay as well as severe intellectual disability. Oral motor dysfunction leads to difficulty with oral coordination, chewing, and swallowing. The majority of individuals do not learn to walk. All individuals lack expressive language, although many have expressive body language and a few have used signs to communicate.</p>
          <p>For most individuals the UNC80 deficiency syndrome is not progressive. Individuals have slow acquisition of skills and do not have the loss of skills suggestive of neurodegeneration.</p>
          <p><bold>Behavioral features.</bold> Some individuals have behavioral difficulties including repetitive and self-stimulatory behaviors and difficulties with emotional regulation. The majority of individuals with UNC80 deficiency are social (i.e., they prefer people to objects). Some individuals show tactile aversion and hypersensitivity to stimuli. Some individuals seek significant oral stimulation.</p>
          <p><bold>Growth.</bold> All individuals have had normal prenatal growth. Postnatally, however, linear growth and weight remained below the 3<sup>rd</sup> centile. Poor feeding exacerbates the growth restriction; however, tube feedings with a calorie-rich diet generally do not result in weight for age above the 3<sup>rd</sup> centile. Individuals do not have evidence of endocrine anomalies that would account for the poor weight gain.</p>
          <p><bold>Gastrointestinal features.</bold> Constipation is common and has been attributed to hypotonia.</p>
          <p><bold>Musculoskeletal features.</bold> Many individuals have congenital club feet. Joint contractures (e.g., hip, elbow, knee) can present from an early age. Later-onset scoliosis can be seen. Ongoing physiotherapy, stretching, and bracing improves some of the limitations encountered with contractures and/or scoliosis. In individuals with more severe club feet or scoliosis, surgery may be considered.</p>
          <p><bold>Ophthalmologic features.</bold> Strabismus has been reported in all affected individuals and nystagmus is seen in half of affected individuals. One individual with structural ocular abnormalities (punctate keratopathy) has been reported. Vision is usually normal.</p>
          <p><bold>Facial features.</bold> The dysmorphic features reported appear to be nonspecific (see <xref ref-type="table" rid="unc80-def.T.frequency_of_clinical_featur">Table 2</xref>).</p>
          <table-wrap id="unc80-def.T.frequency_of_clinical_featur" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Frequency of Clinical Features in Individuals with <italic toggle="yes">UNC80</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" rowspan="2" valign="middle" colspan="2" align="left" scope="colgroup" headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1">Clinical Feature</th>
                  <th id="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Frequency in Individuals w/<italic toggle="yes">UNC80</italic><break/>Pathogenic Variants&#x000a0;<sup>1</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2" id="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1"># w/feature /<break/># reported&#x000a0;<sup>1</sup></th>
                  <th headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2" id="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">% w/feature</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" rowspan="12" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Neurodevelopmental</bold>
                    <break/>
                    <bold>&#x00026; behavioral</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" align="left" rowspan="1" colspan="1">Severe ID or DD</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">19/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Hypotonia</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">19/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Global motor delay</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">13/13</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Feeding difficulties</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">5/6</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">83%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Walking achieved</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">3/6</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">50%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Absent speech or &#x0003c;5 words</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">19/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Dystonic posture of limbs</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">9/9</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Seizures</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">10/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">53%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Arm flapping</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">2/2</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Happy disposition</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">2/2</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Self-injurious behaviors</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">2/2</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Sensory hypersensitivities</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">5/6</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">83%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Growth</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" align="left" rowspan="1" colspan="1">Normal birth parameters</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">12/12</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Postnatal height &#x0003c;3rd centile</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">11/12</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">92%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Postnatal weight &#x0003c;3rd centile</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">11/12</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">92%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Postnatal microcephaly</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">11/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">58%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Gastrointestinal</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" align="left" rowspan="1" colspan="1">Constipation</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">5/6</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">83%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" rowspan="6" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Musculoskeletal</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" align="left" rowspan="1" colspan="1">Scoliosis</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">10/13</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">77%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Joint contractures</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">10/10</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Club feet</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">6/9</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">67%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Long, thin fingers</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">9/9</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Tapering of distal phalanx</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">9/9</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Small hands &#x00026; feet</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">5/6</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">83%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Ophthalmologic</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" align="left" rowspan="1" colspan="1">Strabismus</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">11/11</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Nystagmus</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">2/4</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">50%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" rowspan="11" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Nonspecific</bold>
                    <break/>
                    <bold>facial features</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" align="left" rowspan="1" colspan="1">Triangular face</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">16/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">84%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Frontal bossing</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">5/9</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">56%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Downslanted palpebral fissures</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">10/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">53%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Low-set/posteriorly rotated ears</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">10/17</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">59%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Broad nasal bridge</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">11/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">58%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Anteverted nares</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">11/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">58%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Enlarged nares</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">7/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">37%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Short &#x00026; smooth philtrum</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">10/13</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">77%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Thin vermilion of upper lip</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">8/18</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">44%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Tented vermilion of upper lip</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">10/13</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">77%</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_1" valign="bottom" colspan="1" align="left" scope="row" rowspan="1">Micrognathia</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">10/19</td>
                  <td headers="hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_1_2 hd_h_unc80-def.T.frequency_of_clinical_featur_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">53%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Adapted from <xref ref-type="bibr" rid="unc80-def.REF.valkanas.2016.3106">Valkanas et al [2016]</xref></p>
              </fn>
              <fn>
                <p>ID = intellectual disability</p>
              </fn>
              <fn>
                <p>DD = developmental delay</p>
              </fn>
              <fn>
                <p>1: Total number of individuals with UNC80 deficiency who were assessed for the feature</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Radiographic features.</bold> Although most affected individuals have normal brain MRI findings, nonspecific abnormalities such as a thin corpus callosum, mild diffuse brain atrophy, and borderline mild enlargement of the lateral and third ventricles and of the extra-axial space have been reported [<xref ref-type="bibr" rid="unc80-def.REF.perez.2016.397">Perez et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.shamseldin.2016.210">Shamseldin et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.straypedersen.2016.202">Stray-Pedersen et al 2016</xref>]. The skeletal features seen in affected individuals to date are primarily identified by physical exam.</p>
          <p><bold>Prognosis.</bold> Reported individuals span ages from birth to 15 years [<xref ref-type="bibr" rid="unc80-def.REF.perez.2016.397">Perez et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.shamseldin.2016.210">Shamseldin et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.straypedersen.2016.202">Stray-Pedersen et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.valkanas.2016.3106">Valkanas et al 2016</xref>]. To date, only one individual has died, of complications from infection; postmortem studies of the brain, spinal cord, nerve, muscle, liver, skin, and myocardium did not identify evidence of central nervous malformations or findings attributable to the underlying neurologic disorder [<xref ref-type="bibr" rid="unc80-def.REF.valkanas.2016.3106">Valkanas et al 2016</xref>].</p>
        </sec>
        <sec id="unc80-def.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Correlations of genotype to phenotype have shown that genotype does not predict disease severity or outcome either within or among families.</p>
        </sec>
        <sec id="unc80-def.Nomenclature">
          <title>Nomenclature</title>
          <p>UNC80 deficiency is referred to as &#x0201c;infantile hypotonia with psychomotor retardation and characteristic facies 2&#x0201d; (IHPRF2) in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://omim.org/entry/616801">OMIM</ext-link>.</p>
        </sec>
        <sec id="unc80-def.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence is unknown. Nineteen individuals have been reported to date. UNC80 deficiency is presumed pan ethnic.</p>
        </sec>
      </sec>
      <sec id="unc80-def.Genetically_Related_Allelic_Di">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">UNC80</italic>.</p>
      </sec>
      <sec id="unc80-def.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Based on affected individuals described to date [<xref ref-type="bibr" rid="unc80-def.REF.perez.2016.397">Perez et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.shamseldin.2016.210">Shamseldin et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.straypedersen.2016.202">Stray-Pedersen et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.valkanas.2016.3106">Valkanas et al 2016</xref>], UNC80 deficiency does not have pathognomonic features distinguishing it from the many disorders in which central hypotonia, intellectual disability, and global developmental delay are observed. Description of additional affected individuals may eventually identify such pathognomonic features; however, until then UNC80 deficiency is best considered as clinically indistinguishable from many other genetic causes of hypotonia, global developmental delay, and intellectual disability (some of which are listed in <xref ref-type="table" rid="unc80-def.T.disorders_to_consider_in_the">Table 3</xref>).</p>
        <table-wrap id="unc80-def.T.disorders_to_consider_in_the" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of UNC80 Deficiency</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disorder&#x000a0;<sup>1</sup></th>
                <th id="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene / Genetic Mechanism</th>
                <th id="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing Clinical Features</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypotonia, infantile, with psychomotor retardation and characteristic facies 1<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://omim.org/entry/615419">615419</ext-link>)</td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">NALCN</italic>
                </td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Distinctive facial features incl prominent forehead, short nose, wide mouth, micrognathia, &#x00026; large, low-set ears; neuroaxonal dystrophy; optic atrophy</td>
              </tr>
              <tr>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypotonia, infantile, with psychomotor retardation and characteristic facies 3<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://omim.org/entry/616900">616900</ext-link>)</td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TBCK</italic>
                </td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Distinctive facial features incl coarse face, bitemporal narrowing, highly arched eyebrows, deeply set eyes, high nasal bridge w/anteverted nares, macroglossia, gingival hyperplasia, &#x00026; exaggerated cupid&#x02019;s bow; abnormal brain imaging; optic atrophy</td>
              </tr>
              <tr>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="gr_22q13_3" document-type="chapter">Phelan-McDermid syndrome</related-object>
                </td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Terminal or interstitial deletion of chromosome 22q13.3</td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Normal or accelerated growth, dolichocephaly, ptosis, epicanthal folds, large or prominent ears, pointed chin, fleshy hands, dysplastic toenails, tendency to overheat</td>
              </tr>
              <tr>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Ring chromosome 22</td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Mild prenatal growth deficiency; mild dysmorphic features incl hypertelorism, epicanthal folds, depressed nasal bridge, &#x00026; micrognathia; genitourinary anomalies; coloboma of the iris, choroid, and/or optic nerve; microphthalmia; cleft palate; congenital heart malformations; hernias; internal &#x00026; external ear anomalies</td>
              </tr>
              <tr>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="pws" document-type="chapter">Prader-Willi syndrome</related-object>
                </td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Abnormal parent-specific imprinting w/in PWCR</td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Polyphagia &#x00026; obesity, thin vermilion of upper lip w/down-turned corners of the mouth, genitourinary anomalies, acquisition of speech &#x00026; mobility</td>
              </tr>
              <tr>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="angelman" document-type="chapter">Angelman syndrome</related-object>
                </td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deficient expression or function of the maternally inherited <italic toggle="yes">UBE3A</italic> allele</td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Bursts of laughter, macrostomia, tongue protrusion, prognathism, widely spaced teeth, mild cortical atrophy</td>
              </tr>
              <tr>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Glass syndrome<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://omim.org/entry/612313">612313</ext-link>)</td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SATB2</italic>
                </td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Cleft palate, arachnodactyly, joint laxity, ectodermal anomalies</td>
              </tr>
              <tr>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Rett syndrome (see <related-object link-type="booklink" source-id="gene" document-id="rett" document-type="chapter"><italic toggle="yes">MECP2</italic>-Related Disorders</related-object>)</td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MECP2</italic>
                </td>
                <td headers="hd_h_unc80-def.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Postnatal microcephaly, seizures, poor growth, esotropia, scoliosis, repetitive behaviors</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>PWCR = Prader-Willi critical region</p>
            </fn>
            <fn id="unc80-def.TF.3.1">
              <label>1. </label>
              <p>See hyperlinked <italic toggle="yes">GeneReview</italic> or OMIM phenotype entry for more information.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="unc80-def.Management">
        <title>Management</title>
        <sec id="unc80-def.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with UNC80 deficiency, the evaluations and referrals summarized in <xref ref-type="table" rid="unc80-def.T.recommended_evaluations_foll">Table 4</xref> (if not performed as part of the evaluation that led to diagnosis) are recommended.</p>
          <table-wrap id="unc80-def.T.recommended_evaluations_foll" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Recommended Evaluations Following Initial Diagnosis</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Organ System</th>
                  <th id="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Evaluation</th>
                  <th id="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Comment</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Constitutional</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Growth assessment incl height, weight, &#x00026; head circumference</td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Eyes</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Ophthalmologic eval</td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Gastrointestinal</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Feeding eval</td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Musculoskeletal</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Orthopedic eval</td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">If club feet and/or scoliosis is present</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Neurologic</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">EEG</td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">If neurologic history suggests presence of seizures</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Psychiatric</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Psychiatric eval</td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">If behavioral problems are present</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Miscellaneous / Other</bold>
                  </td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Psychoeducational and/or developmental evals (physical therapy, occupational therapy, speech therapy evals) to assess developmental delays &#x00026; facilitate appropriate interventions</td>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.recommended_evaluations_foll_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Consultation w/clinical geneticist and/or genetic counselor</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec id="unc80-def.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <table-wrap id="unc80-def.T.treatment_of_manifestations" orientation="portrait" position="anchor">
            <label>Table 5. </label>
            <caption>
              <p>Treatment of Manifestations in Individuals with UNC80 Deficiency</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Manifestation</th>
                  <th id="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Treatment</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Ocular abnormalities (nystagmus/strabismus)</td>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Ophthalmologic management</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Oral feeding difficulties</td>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">G-tube feeding</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Constipation</td>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Standard management</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Orthopedic abnormalities (club feet, scoliosis, joint contractures)</td>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Braces and/or corrective surgery</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Seizures</td>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Antiepileptic drugs</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Self-injurious behavior</td>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Behavior modification therapy</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypo/hypertonia, gross motor delays, sensory processing difficulties</td>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Physical therapy, occupational therapy</td>
                </tr>
                <tr>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Absent speech</td>
                  <td headers="hd_h_unc80-def.T.treatment_of_manifestations_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sign language instruction; consider alternate forms of communication</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <sec id="unc80-def.Global_Developmental_Disabilit">
            <title>Global Developmental Disability / Intellectual Disability Educational Issues</title>
            <p><bold>Ages 0-3 years.</bold> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the United States, early intervention is a federally funded program available in all states.</p>
            <p><bold>Ages 3-5 years.</bold> In the United States, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p>
            <p>
              <bold>Ages 5-21 years</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>In the United States, an IEP based on the individual&#x02019;s level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</p>
              </list-item>
              <list-item>
                <p>Discussion about transition plans and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</p>
              </list-item>
            </list>
            <p><bold>All ages.</bold> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life. Some issues to consider:</p>
            <list list-type="bullet">
              <list-item>
                <p>Private supportive therapies based on the affected individual&#x02019;s needs may be considered. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p>
              </list-item>
              <list-item>
                <p>In the United States:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</p>
                  </list-item>
                  <list-item>
                    <p>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</p>
                  </list-item>
                </list>
              </list-item>
            </list>
          </sec>
          <sec id="unc80-def.Motor_Dysfunction">
            <title>Motor Dysfunction</title>
            <p>
              <bold>Gross motor dysfunction</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Physical therapy is recommended to maximize mobility.</p>
              </list-item>
              <list-item>
                <p>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, lifts, bath chairs, orthotics, adaptive strollers).</p>
              </list-item>
            </list>
            <p><bold>Fine motor dysfunction.</bold> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p>
            <p><bold>Oral motor dysfunction.</bold> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for affected individuals who have difficulty feeding due to poor oral motor control.</p>
            <p><bold>Communication issues.</bold> Consider evaluation for alternative means of communication (e.g., <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.asha.org/NJC/AAC/">Augmentative and Alternative Communication</ext-link>) for individuals who have expressive language difficulties.</p>
          </sec>
        </sec>
        <sec id="unc80-def.Surveillance">
          <title>Surveillance</title>
          <p>Annual evaluation with the following specialists is appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Pediatrician for growth assessment</p>
            </list-item>
            <list-item>
              <p>Neurologist to identify and manage seizures</p>
            </list-item>
            <list-item>
              <p>Orthopedist for evaluation of contractures and back examination for scoliosis</p>
            </list-item>
            <list-item>
              <p>Ophthalmologist for ocular manifestations and corrective therapy if needed</p>
            </list-item>
          </list>
        </sec>
        <sec id="unc80-def.Evaluation_of_Relatives_at_Ris">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="unc80-def.Related_Genetic_Counseling_Iss">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="unc80-def.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="unc80-def.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="unc80-def.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>UNC80 deficiency is inherited in an autosomal recessive manner.</p>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">UNC80</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an individual with UNC80 deficiency are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">UNC80</italic>.</p>
            </list-item>
            <list-item>
              <p>To date, no individuals diagnosed with UNC80 deficiency have been known to reproduce.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">UNC80</italic> pathogenic variant.</p>
        </sec>
        <sec id="unc80-def.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">UNC80</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="unc80-def.Related_Genetic_Counseling_Iss">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="unc80-def.Prenatal_Testing_and_Preimplan">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">UNC80</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="unc80-def.Resources">
        <title>Resources</title>
      </sec>
      <sec id="unc80-def.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">UNC80</italic> transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_032504.1">NM_032504.1</ext-link> has 64 exons. <italic toggle="yes">UNC80</italic> transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_182587.3">NM_182587.3</ext-link> has 63 exons. See <related-object source-id="gene" document-id="unc80-def" object-id="unc80-def.molgen.TA">Table A</related-object>, <bold>Gene</bold> for a detailed summary of gene and protein information.</p>
        <p><bold>Pathogenic variants.</bold> Initially detected in Bedouin families, <italic toggle="yes">UNC80</italic> pathogenic variants have subsequently been reported among individuals from many ethnicities. Variants causing loss of functional UNC80 have been identified throughout the gene.</p>
        <p><bold>Normal gene product.</bold> UNC80 isoform 1 has 3258 amino acids. Isoform 2 has 3234 amino acids. No functional domains have been well characterized. The UNC80 protein is part of a channel complex including NACLN and UNC79 [<xref ref-type="bibr" rid="unc80-def.REF.lu.2010.488">Lu et al 2010</xref>]. The similarity of the neurologic phenotypes of fruit flies and mice with loss of the UNC79, UNC80, and NALCN orthologs and the finding of direct association among the three proteins in mouse brains demonstrates the interdependency of these proteins in the channel complex [<xref ref-type="bibr" rid="unc80-def.REF.lu.2007.371">Lu et al 2007</xref>, <xref ref-type="bibr" rid="unc80-def.REF.yeh.2008.e55">Yeh et al 2008</xref>, <xref ref-type="bibr" rid="unc80-def.REF.speca.2010.e1001057">Speca et al 2010</xref>, <xref ref-type="bibr" rid="unc80-def.REF.alsayed.2013.721">Al-Sayed et al 2013</xref>, <xref ref-type="bibr" rid="unc80-def.REF.k_ro_lu.2013.515">K&#x000f6;ro&#x0011f;lu et al 2013</xref>, <xref ref-type="bibr" rid="unc80-def.REF.lear.2013.e78147">Lear et al 2013</xref>, <xref ref-type="bibr" rid="unc80-def.REF.perez.2016.397">Perez et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.shamseldin.2016.210">Shamseldin et al 2016</xref>, <xref ref-type="bibr" rid="unc80-def.REF.straypedersen.2016.202">Stray-Pedersen et al 2016</xref>].</p>
        <p>This channel complex, which is predominantly expressed in the brain, is a voltage-insensitive and nonselective sodium leak channel [<xref ref-type="bibr" rid="unc80-def.REF.yu.2005.387">Yu et al 2005</xref>, <xref ref-type="bibr" rid="unc80-def.REF.lu.2007.371">Lu et al 2007</xref>, <xref ref-type="bibr" rid="unc80-def.REF.snutch.2007.505">Snutch &#x00026; Monteil 2007</xref>]. In cultured hippocampal neurons, it contributes to Na<sup>+</sup> leak at voltages close to the resting membrane potential, and extracellular Ca<sup>2+</sup> regulates neuronal excitability by controlling the NALCN-dependent Na<sup>+</sup>-leak current. The coupling between extracellular Ca<sup>2+</sup> and NALCN occurs via a G protein-coupled receptor. UNC80 bridges NALCN to UNC79, and the presence of UNC80 and UNC79 are essential for NALCN channel function [<xref ref-type="bibr" rid="unc80-def.REF.lu.2010.488">Lu et al 2010</xref>, <xref ref-type="bibr" rid="unc80-def.REF.lear.2013.e78147">Lear et al 2013</xref>, <xref ref-type="bibr" rid="unc80-def.REF.cochetbissuel.2014.132">Cochet-Bissuel et al 2014</xref>]. In mouse brain, both NALCN and UNC80 are tyrosine phosphorylated. NALCN is a cation channel activated by substance P receptor, and the coupling from receptor to channel is facilitated by UNC80 and Src kinases [<xref ref-type="bibr" rid="unc80-def.REF.lu.2009.741">Lu et al 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Recessive loss-of-function biallelic pathogenic variants of <italic toggle="yes">UNC80</italic> cause UNC80 deficiency.</p>
      </sec>
      <sec id="unc80-def.References">
        <title>References</title>
        <sec id="unc80-def.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="unc80-def.Literature_Cited.reflist0">
            <ref id="unc80-def.REF.alsayed.2013.721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Sayed</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Zaidan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albakheet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenana</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Yafee</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Dosary</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sheddi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Muheiza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Qubbaj</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lakmache</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Hindi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghaziuddin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colak</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaya</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in NALCN cause an autosomal-recessive syndrome with severe hypotonia, speech impairment, and cognitive delay.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2013</year>
                <volume>93</volume>
                <fpage>721</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24075186</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.cochetbissuel.2014.132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cochet-Bissuel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lory</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteil</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>The sodium leak channel, NALCN, in health and disease.</article-title>
                <source>Front Cell Neurosci.</source>
                <year>2014</year>
                <volume>8</volume>
                <fpage>132</fpage>
                <pub-id pub-id-type="pmid">24904279</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.k_ro_lu.2013.515">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;ro&#x0011f;lu</surname>
                    <given-names>&#x000c7;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seven</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolun</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Recessive truncating NALCN mutation in infantile neuroaxonal dystrophy with facial dysmorphism.</article-title>
                <source>J Med Genet.</source>
                <year>2013</year>
                <volume>50</volume>
                <fpage>515</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">23749988</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.lear.2013.e78147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lear</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darrah</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldrich</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gebre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nash</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allada</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>UNC79 and UNC80, putative auxiliary subunits of the NARROW ABDOMEN ion channel, are indispensable for robust circadian locomotor rhythms in Drosophila.</article-title>
                <source>PLoS One.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>e78147</fpage>
                <pub-id pub-id-type="pmid">24223770</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.lu.2007.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Das</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm.</article-title>
                <source>Cell.</source>
                <year>2007</year>
                <volume>129</volume>
                <fpage>371</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">17448995</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.lu.2009.741">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Das</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80.</article-title>
                <source>Nature.</source>
                <year>2009</year>
                <volume>457</volume>
                <fpage>741</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19092807</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.lu.2010.488">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex.</article-title>
                <source>Neuron.</source>
                <year>2010</year>
                <volume>68</volume>
                <fpage>488</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">21040849</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.perez.2016.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kadir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volodarsky</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noyman</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flusser</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shorer</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gradstein</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birnbaum</surname>
                    <given-names>RY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birk</surname>
                    <given-names>OS</given-names>
                  </name>
                </person-group>
                <article-title>UNC80 mutation causes a syndrome of hypotonia, severe intellectual disability, dyskinesia and dysmorphism, similar to that caused by mutations in its interacting cation channel NALCN.</article-title>
                <source>J Med Genet.</source>
                <year>2016</year>
                <volume>53</volume>
                <fpage>397</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">26545877</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.shamseldin.2016.210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shamseldin</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faqeih</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alasmari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaki</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkuraya</surname>
                    <given-names>FS</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in UNC80, encoding part of the UNC79-UNC80-NALCN channel complex, cause autosomal-recessive severe infantile encephalopathy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2016</year>
                <volume>98</volume>
                <fpage>210</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">26708753</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.snutch.2007.505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Snutch</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteil</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>The sodium "leak" has finally been plugged.</article-title>
                <source>Neuron.</source>
                <year>2007</year>
                <volume>54</volume>
                <fpage>505</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17521564</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.speca.2010.e1001057">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Speca</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chihara</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashique</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowers</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierce-Shimomura</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabbee</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speed</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gularte</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitwood</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medrano</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonner</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eger</surname>
                    <given-names>EI</given-names>
                    <suffix>2nd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntire</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <article-title>Conserved role of unc-79 in ethanol responses in lightweight mutant mice.</article-title>
                <source>PLoS Genet.</source>
                <year>2010</year>
                <volume>6</volume>
                <fpage>e1001057</fpage>
                <pub-id pub-id-type="pmid">20714347</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.straypedersen.2016.202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stray-Pedersen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobben</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prescott</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aranda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alders</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerstner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aslaksen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000e9;treault</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartley</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhangiani</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muzny</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarailo-Graovac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Karnebeek</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>G</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Biallelic mutations in UNC80 cause persistent hypotonia, encephalopathy, growth retardation, and severe intellectual disability.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2016</year>
                <volume>98</volume>
                <fpage>202</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">26708751</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.valkanas.2016.3106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valkanas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunham</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maduro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>du Souich</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rupps</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baradaran-Heravi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flynn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malicdan</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerkoel</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic evolution of UNC80 loss of function.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2016</year>
                <volume>170</volume>
                <fpage>3106</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">27513830</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.yeh.2008.e55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yeh</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouhours</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hung</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoyagi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melnik-Martinez</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schafer</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>A putative cation channel, NCA-1, and a novel protein, UNC-80, transmit neuronal activity in C. elegans.</article-title>
                <source>PLoS Biol.</source>
                <year>2008</year>
                <volume>6</volume>
                <fpage>e55</fpage>
                <pub-id pub-id-type="pmid">18336069</pub-id>
              </element-citation>
            </ref>
            <ref id="unc80-def.REF.yu.2005.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yarov-Yarovoy</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutman</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catterall</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Overview of molecular relationships in the voltage-gated ion channel superfamily.</article-title>
                <source>Pharmacol Rev.</source>
                <year>2005</year>
                <volume>57</volume>
                <fpage>387</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">16382097</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="unc80-def.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="unc80-def.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>21 September 2017 (sw) Review posted live</p>
            </list-item>
            <list-item>
              <p>17 January 2017 (cds) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
